Mark Okey Decker, Jr. Purchases 6,875 Shares of Global Medical REIT (NYSE:XRN) Stock

Global Medical REIT Inc. (NYSE:XRN) CEO Mark Okey Decker, Jr. purchased 6,875 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was acquired at an average price of $35.92 per share, for a total transaction of $246,950.00. Following the acquisition, the chief executive officer directly owned 75,199 shares of the company’s stock, valued at $2,701,148.08. This trade represents a 10.06% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Global Medical REIT Price Performance

XRN opened at $37.28 on Friday. The company has a quick ratio of 0.68, a current ratio of 0.59 and a debt-to-equity ratio of 1.37. Global Medical REIT Inc. has a 52-week low of $29.05 and a 52-week high of $39.93. The company has a 50 day moving average of $36.62 and a two-hundred day moving average of $35.81. The company has a market cap of $493.59 million, a P/E ratio of 10.02 and a beta of 1.09.

Global Medical REIT (NYSE:XRN) last released its quarterly earnings data on Wednesday, August 5th. The company reported $4.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $3.95. Global Medical REIT had a net margin of 36.82% and a return on equity of 13.31%. The company had revenue of $39.75 million during the quarter. On average, analysts expect that Global Medical REIT Inc. will post 2.89 earnings per share for the current year.

Global Medical REIT News Roundup

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: CEO Mark Okey Decker, Jr. bought 8,000 shares at $35.88 and an additional 6,875 shares at $35.92, while COO Aaron Robert Roseth purchased 13,500 shares at $36.73. Director Charles Fitzgerald also acquired 14,000 shares at $35.78. The reported purchases represent more than $1.5 million of direct insider buying, a potentially bullish signal. Global Medical REIT CEO Purchases Shares
• Positive Sentiment: Global Medical REIT’s latest quarterly results significantly exceeded expectations: earnings per share were $4.78 versus the $0.83 consensus estimate, with revenue of $39.75 million. The company also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for investor interest.
• Neutral Sentiment: Analyst opinion remains mixed, with two Buy ratings, five Holds and one Sell. The average price target is $40.25, above the recent trading range, but Compass Point maintains a $38 target while Citizens JMP has a $42 target. The overall consensus rating is Hold.
• Neutral Sentiment: Institutional investors own approximately 57.52% of XRN. Recent filings show several funds increasing positions, although the disclosed transactions are not necessarily a near-term catalyst.
• Neutral Sentiment: Coverage also discusses Global Medical REIT’s rebranding and transition to Chiron Real Estate, which may create uncertainty about the company’s identity and strategic direction. Chiron Real Estate rebrand article
• Negative Sentiment: The REIT remains relatively leveraged, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68. High debt and limited liquidity could weigh on valuation if interest rates stay elevated or healthcare property conditions weaken.

Hedge Funds Weigh In On Global Medical REIT

A number of institutional investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd boosted its position in Global Medical REIT by 1,001.4% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock valued at $27,000 after buying an additional 721 shares during the last quarter. Fifth Third Bancorp grew its stake in shares of Global Medical REIT by 35.3% during the fourth quarter. Fifth Third Bancorp now owns 1,417 shares of the company’s stock valued at $48,000 after acquiring an additional 370 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of Global Medical REIT by 70.3% during the second quarter. Tower Research Capital LLC TRC now owns 7,379 shares of the company’s stock worth $51,000 after acquiring an additional 3,046 shares during the last quarter. B. Riley Wealth Advisors Inc. purchased a new stake in shares of Global Medical REIT during the second quarter worth about $78,000. Finally, Virtus Advisers LLC lifted its stake in shares of Global Medical REIT by 46.5% in the fourth quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock worth $82,000 after acquiring an additional 768 shares in the last quarter. Institutional investors and hedge funds own 57.52% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Wall Street Zen downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Citizens Jmp boosted their price objective on Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a research note on Tuesday, May 26th. BMO Capital Markets upped their target price on Global Medical REIT from $39.00 to $40.00 and gave the stock a “market perform” rating in a research report on Monday, July 13th. Weiss Ratings lowered Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, July 30th. Finally, Compass Point reiterated a “neutral” rating and set a $38.00 target price (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. Two analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $40.25.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.